Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion

Inclusion Criteria: * Recipients of first or second cadaveric or living donor kidney transplantation or first cadaveric or living donor liver transplantation * Receiving tacrolimus as a primary immunosuppressant * Currently on any diabetic agent or meets the American Diabetes Association definition of diabetes mellitus Exclusion Criteria: * History of treated diabetes mellitus prior to transplantation * Less than 2 weeks post-transplantation for kidney and less than 8 weeks for liver * Greater than 36 months post-transplantation * Onset of diabetes is greater than 12 months prior to time of study entry * Has unacceptable or unstable graft function Other protocol-defined inclusion/exclusion criteria may apply.